Literature DB >> 2376749

Improved correlation of magnetic resonance imaging (MRI) with clinical status in multiple sclerosis (MS) by use of an extensive standardized imaging-protocol.

L Truyen1, J Gheuens, F L Van de Vyver, P M Parizel, G V Peersman, J J Martin.   

Abstract

In a previous study we have shown that the sensitivity of magnetic resonance imaging (MRI) for the detection of multiple sclerosis (MS) lesions was improved significantly, especially in the infratentorial region, by use of an extensive standardized MRI-protocol consisting of sagittal T1, axial protondensity and axial T2, and sagittal protondensity and sagittal moderately T2-weighted images. The goal of the present study was to assess whether the clinical correlation of the visualized lesions had improved accordingly. Using a scoring system based on lesion dimensions, we compared 70 MRI examinations performed in 25 patients with definite MS, with the relevant clinical data as given by the Expanded Disability Status Scale (EDSS) and Functional System scale (FS). We found a significant correlation (r = 0.66, P = 0.0001) between the MRI score and the EDSS. Significant correlations also existed between MRI scores and cerebellar and brainstem FS scores. These correlations were consistently higher than those reported by other authors. We conclude that a standardized MRI examination, including sagittal protondensity and moderately T2-weighted images, should be performed in every MS patient. The improved clinical correlation could be of importance in follow-up studies when assessing the efficacity of therapy.

Entities:  

Mesh:

Year:  1990        PMID: 2376749     DOI: 10.1016/0022-510x(90)90130-f

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Computerised volumetric analysis of lesions in multiple sclerosis using new semi-automatic segmentation software.

Authors:  P Dastidar; T Heinonen; T Vahvelainen; I Elovaara; H Eskola
Journal:  Med Biol Eng Comput       Date:  1999-01       Impact factor: 2.602

2.  Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups.

Authors:  M Rovaris; D Barnes; N Woodrofe; G H du Boulay; J W Thorpe; A J Thompson; W I McDonald; D H Miller
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

Review 3.  Immunotherapy for multiple sclerosis.

Authors:  R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

4.  Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis.

Authors:  F Barkhof; M W Tas; S T Frequin; P Scheltens; O R Hommes; J J Nauta; J Valk
Journal:  Neuroradiology       Date:  1994-07       Impact factor: 2.804

5.  Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis.

Authors:  M Filippi; A Campi; S Mammi; V Martinelli; T Locatelli; G Scotti; S Amadio; N Canal; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

6.  Association between retinal nerve fiber layer thickness and magnetic resonance imaging findings and intelligence in patients with multiple sclerosis.

Authors:  Fereshteh Ashtari; Parisa Emami; Mojtaba Akbari
Journal:  Adv Biomed Res       Date:  2015-10-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.